Back to Search
Start Over
Disease correction the iPSC way: advances in iPSC-based therapy
- Source :
- Clinical pharmacology and therapeutics. 89(5)
- Publication Year :
- 2011
-
Abstract
- Pluripotent stem cells possess the capacity for self-renewal and the ability to differentiate into all cell types of the three embryonic germ layers. Accordingly, given their potential use in regenerative medicine, they have long attracted the attention of researchers. Embryonic stem cells (ESCs) represent the model pluripotent stem cell population. However, the use of ESCs in regenerative therapies faces major hurdles—namely, immune rejection and the necessity to use early-stage embryos for ESC isolation. Clinical Pharmacology & Therapeutics (2011) 89 5, 746–749. doi:10.1038/clpt.2010.341
- Subjects :
- Pathology
medicine.medical_specialty
Cell type
Population
Induced Pluripotent Stem Cells
Embryonic germ
Disease
Regenerative Medicine
Regenerative medicine
law.invention
law
medicine
Animals
Humans
Pharmacology (medical)
education
Induced pluripotent stem cell
Pharmacology
education.field_of_study
Clinical pharmacology
business.industry
Genetic Therapy
Embryonic stem cell
embryonic structures
Gene Targeting
business
Neuroscience
Subjects
Details
- ISSN :
- 15326535
- Volume :
- 89
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Clinical pharmacology and therapeutics
- Accession number :
- edsair.doi.dedup.....729dbacd806577741534e3e6258cfed5